Table 6.
Population | Unadjusted Hazard Ratio (95% CI) | P Value |
---|---|---|
At 2 Months, All Participants (n = 532) | ||
FujiLAM negative | Ref. | |
FujiLAM positive | 3.6 (2.0–6.2) | <.001 |
AlereLAM negative | Ref. | |
AlereLAM positive | 6.7 (3.8–11.7) | <.001 |
At 2 Months, Definite TB (n = 66) | ||
FujiLAM negative | Ref. | |
FujiLAM positive | 6.2 (0.8–46.4] | .077 |
AlereLAM negative | Ref. | |
AlereLAM positive | 8.7 (2.0–38.0) | .004 |
At 6 Months, All participants (n = 532) | ||
FujiLAM negative | Ref. | |
FujiLAM positive | 4.8 (3.0–7.6) | <.001 |
AlereLAM negative | Ref. | |
AlereLAM positive | 6.2 (3.8–10.1) | <.001 |
At 6 Months, Definite TB (n = 66) | ||
FujiLAM negative | Ref. | |
FujiLAM positive | 3.7 (0.9–16.0) | .075 |
AlereLAM negative | Ref. | |
AlereLAM positive | 5.2 (1.7–15.3) | .003 |
Abbreviations: CI, confidence interval; Ref., reference; TB, tuberculosis.